David Cibula
#161,533
Most Influential Person Now
Researcher
David Cibula's AcademicInfluence.com Rankings
David Cibulacomputer-science Degrees
Computer Science
#9333
World Rank
#9806
Historical Rank
Machine Learning
#4056
World Rank
#4105
Historical Rank
Artificial Intelligence
#4395
World Rank
#4456
Historical Rank
Database
#6302
World Rank
#6534
Historical Rank
Download Badge
Computer Science
David Cibula's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is David Cibula Influential?
(Suggest an Edit or Addition)David Cibula's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma (2020) (559)
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. (2015) (478)
- A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms (2019) (287)
- The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (2018) (277)
- Tubal ligation and the risk of ovarian cancer: review and meta-analysis. (2011) (262)
- Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. (2000) (260)
- Hormonal contraception and risk of cancer. (2010) (238)
- Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer: The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO (2010) (232)
- The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. (2018) (198)
- Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. (2012) (182)
- Diagnosis, treatment, and follow-up of borderline ovarian tumors. (2012) (168)
- Bone quality assessment in type 2 diabetes mellitus (2014) (152)
- Insulin sensitivity in women with polycystic ovary syndrome. (2004) (143)
- Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial (2020) (136)
- Combined oral contraceptives in the treatment of polycystic ovary syndrome. (2005) (136)
- 2017 Update on the Querleu–Morrow Classification of Radical Hysterectomy (2017) (135)
- Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer. (2008) (135)
- Role of DNA Methylation and Epigenetic Silencing of HAND2 in Endometrial Cancer Development (2013) (131)
- Pregnancy outcome in women with PCOS and in controls matched by age and weight. (2003) (129)
- Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial. (2013) (125)
- SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer (2020) (123)
- Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis. (2012) (121)
- Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study. (2013) (119)
- The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer (2012) (115)
- New classification system of radical hysterectomy: emphasis on a three-dimensional anatomic template for parametrial resection. (2011) (109)
- Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. (2004) (105)
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges (2018) (104)
- The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer (2017) (104)
- The role of androgens in determining acne severity in adult women (2000) (103)
- An International Series on Abdominal Radical Trachelectomy: 101 Patients and 28 Pregnancies (2012) (101)
- Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis (2011) (99)
- A prospective study examining the incidence of asymptomatic and symptomatic lymphoceles following lymphadenectomy in patients with gynecological cancer. (2015) (97)
- European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery (2016) (96)
- European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery (2017) (92)
- LION: Lymphadenectomy in ovarian neoplasms—A prospective randomized AGO study group led gynecologic cancer intergroup trial. (2017) (88)
- High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. (2013) (87)
- PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (2020) (84)
- The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. (2018) (84)
- Women's contraceptive practices and sexual behaviour in Europe (2008) (83)
- Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. (2021) (80)
- Sentinel lymph node biopsy in the management of gynecologic cancer (2015) (79)
- DNA methylation markers for early detection of women's cancer: promise and challenges. (2014) (76)
- The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients. (2005) (75)
- Metabolic syndrome in young Czech women with polycystic ovary syndrome. (2005) (75)
- The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers (2014) (72)
- Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study. (2019) (72)
- Abdominal Radical Trachelectomy in Fertility-Sparing Treatment of Early-Stage Cervical Cancer (2009) (72)
- The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome. (2001) (70)
- Steroid metabolome in fetal and maternal body fluids in human late pregnancy (2010) (70)
- Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. (2019) (67)
- Laparoscopic abdominal radical trachelectomy. (2005) (67)
- Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation (2013) (63)
- Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study. (2012) (61)
- Pelvic lymphadenectomy in cervical cancer--surgical anatomy and proposal for a new classification system. (2010) (61)
- Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) (2020) (61)
- HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: A proof of principle study (2009) (61)
- Circulating levels of pregnanolone isomers during the third trimester of human pregnancy (2007) (60)
- A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival (2014) (58)
- Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths. (2014) (54)
- Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin. (2002) (53)
- Prediction of insulin sensitivity in nonobese women with polycystic ovary syndrome. (2002) (53)
- Ultrasound‐guided tru‐cut biopsy of abdominal and pelvic tumors in gynecology (2010) (52)
- The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer (2018) (50)
- Underlying mechanisms of ovarian cancer risk reduction after tubal ligation (2011) (50)
- Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer. (2016) (50)
- Update on abdominal radical trachelectomy. (2008) (49)
- MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum (2020) (46)
- Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome? (2001) (44)
- Factors affecting sonographic preoperative local staging of endometrial cancer (2014) (44)
- Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence. (2012) (44)
- A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX) (2019) (44)
- Neuroactive steroids, their precursors, and polar conjugates during parturition and postpartum in maternal and umbilical blood: 1. identification and simultaneous determination of pregnanolone isomers (2000) (44)
- ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma (2021) (43)
- Is insulin resistance an essential component of PCOS?: The influence of confounding factors. (2004) (43)
- Methylation patterns in serum DNA for early identification of disseminated breast cancer (2017) (43)
- Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature. (2018) (41)
- Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics. (2011) (41)
- Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists (2019) (39)
- Lymphocele: prevalence and management in gynecological malignancies (2014) (39)
- Ultrasound- guided tru- cut biopsy in the management of advanced abdomino- pelvic tumors (2007) (39)
- Sexual morbidity following radical hysterectomy for cervical cancer (2010) (39)
- Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study (2017) (38)
- Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer. (2016) (37)
- Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II (2021) (36)
- Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial. (2022) (36)
- Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy. (2007) (36)
- The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia. (2014) (36)
- Oncological Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Systematic Review (2015) (36)
- ESGO Survey on Current Practice in the Management of Cervical Cancer (2018) (35)
- Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome (2007) (35)
- Sentinel node (SLN) biopsy in the management of locally advanced cervical cancer. (2009) (33)
- Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement (2019) (33)
- Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal blood: 2. Time profiles of pregnanolone isomers (2001) (33)
- Pelvic Lymphadenectomy Improves Survival in Patients With Cervical Cancer With Low-Volume Disease in the Sentinel Node: A Retrospective Multicenter Cohort Study (2014) (32)
- Ultrasound in Gynecological Cancer: Is It Time for Re-evaluation of Its Uses? (2015) (31)
- Diagnostic Accuracy of Ultrasound and MRI in the Mapping of Deep Pelvic Endometriosis Using the International Deep Endometriosis Analysis (IDEA) Consensus (2020) (30)
- The best correlation of the new index of hyperandrogenism with the grade of increased body hair. (2000) (30)
- Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial. (2020) (30)
- Impact of risk factors on prevalence of anal HPV infection in women with simultaneous cervical lesion. (2015) (29)
- Follow-up in Gynecological Malignancies: A State of Art (2015) (29)
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors (2021) (29)
- Sentinel lymph node status in patients with locally advanced cervical cancers and impact of neoadjuvant chemotherapy. (2012) (29)
- International radical trachelectomy assessment: IRTA study (2019) (29)
- Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer (2019) (29)
- The genetic landscape of 87 ovarian germ cell tumors. (2018) (28)
- Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women (2008) (27)
- SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm. (2018) (27)
- European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer (2020) (27)
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. (2021) (27)
- ISUOG Consensus Statement on rationalization of gynecological ultrasound services in context of SARS‐CoV‐2 (2020) (26)
- SUCCOR cone study: conization before radical hysterectomy (2022) (25)
- Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20μg and Drospirenone 3mg (2006) (24)
- Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008. (2014) (23)
- Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer (2013) (23)
- The Work Place Educational Climate in Gynecological Oncology Fellowships Across Europe: The Impact of Accreditation (2015) (23)
- Factors Affecting Spontaneous Voiding Recovery After Radical Hysterectomy (2010) (23)
- Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience. (2016) (22)
- Olaparib monotherapy versus (vs) chemotherapy for germline BRCA-mutated (gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase III SOLO3 trial. (2019) (22)
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors (2021) (22)
- Serous tubal intraepithelial carcinoma (STIC) – clinical impact and management (2016) (21)
- Current Clinical Practice in Cytoreductive Surgery for Advanced Ovarian Cancer: A European Survey (2011) (21)
- Validation of ultrasound strategies to assess tumor extension and to predict high‐risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)‐4 cohort (2020) (21)
- Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery (2018) (21)
- The Diagnostic Accuracy of Ultrasound in Assessment of Myometrial Invasion in Endometrial Cancer: Subjective Assessment versus Objective Techniques (2017) (21)
- Pelvic floor reconstruction by modified rectus abdominis myoperitoneal (MRAM) flap after pelvic exenterations. (2017) (20)
- Role of D327N sex hormone-binding globulin gene polymorphism in the pathogenesis of polycystic ovary syndrome (2006) (20)
- Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study (2017) (20)
- The association of enchondromatosis with malignant transformed chondrosarcoma and ovarian juvenile granulosa cell tumor (Ollier disease). (2017) (20)
- A phase II randomized open-label study of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with weekly paclitaxel versus weekly paclitaxel in patients with platinum-resistant/refractory ovarian cancers. (2014) (19)
- Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study. (2020) (19)
- Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer (2021) (19)
- Late morbidity following nerve-sparing radical hysterectomy. (2010) (19)
- Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II (2019) (19)
- SUCCOR study. An international european cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 (FIGO 2009, <4 cm) cervical cancer operated in 2013–2014 (2019) (19)
- Immunological configuration of ovarian carcinoma: features and impact on disease outcome (2021) (18)
- Local Control After Tailored Surgical Treatment of Early Cervical Cancer (2011) (18)
- Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions (2016) (18)
- High-Risk Human Papillomavirus DNA in the Primary Tumor, Sentinel, and Nonsentinel Pelvic Lymph Nodes in Patients With Early-Stage Cervical Cancer: A Correlation With Histopathology (2009) (17)
- Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer) (2019) (17)
- Surgical education and training in gynecologic oncology I: European perspective. (2009) (17)
- Uterine Tumors with Neuroectodermal Differentiation. A Report of 4 Cases (2010) (16)
- Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group (2021) (16)
- Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal and umbilical blood: 3.3β-hydroxy-5-ene steroids (2002) (16)
- European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015 (2015) (16)
- Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. (2022) (15)
- A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial (2014) (15)
- Impaired Glucose Metabolism in Women with Polycystic Ovary Syndrome (2009) (15)
- Acute exacerbation of recurrent pelvic inflammatory disease. Laparoscopic findings in 141 women with a clinical diagnosis. (2001) (15)
- Ultrasonographic appearance of metastatic non‐gynecological pelvic tumors (2012) (15)
- Cancer Antigen 125: Lost to Follow-Up? (2012) (14)
- The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples (2022) (14)
- ATALANTE (ENGOT-ov29): A randomized, double-blinded, phase III study of atezolizumab versus placebo in patients with late relapse of epithelial ovarian, fallopian tube, or peritoneal cancer treated by platinum-based chemotherapy and bevacizumab. (2018) (14)
- A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial) (2020) (13)
- 1 MILO/ENGOT-OV11: Phase-3 study of binimetinib versus physician’s choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum (2019) (13)
- Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases (2015) (13)
- The association among cervical, anal, and oral HPV infections in high-risk and low-risk women (2019) (12)
- Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study (2020) (12)
- Primary pure large-cell neuroendocrine carcinoma of the ovary. (2008) (12)
- Cord blood levels of potentially neurotoxic pollutants (polychlorinated biphenyls, lead and cadmium) in the areas of Prague (Czech Republic) and Katowice (Poland). Comparison with reference values in The Netherlands. The Czech/Polish/Dutch/German Research Team. (1994) (12)
- LBA32 Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study (2020) (11)
- Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer Patients (2021) (11)
- Open Versus Minimally Invasive Radical Trachelectomy in Early-Stage Cervical Cancer: International Radical Trachelectomy Assessment Study. (2021) (11)
- Identification of novel HNF1B mRNA splicing variants and their qualitative and semi-quantitative profile in selected healthy and tumour tissues (2020) (11)
- ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. (2020) (11)
- Localization of the Sentinel Node of the Upper Outer Breast Quadrant in the Axillary Quadrants (2007) (11)
- The DNA methylome of cervical cells can predict the presence of ovarian cancer (2022) (11)
- Synchronous endometrioid endometrial and ovarian carcinomas are biologically related: A clinico-pathological and molecular (next generation sequencing) study of 22 cases (2018) (11)
- The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. (2021) (10)
- ESGO Statement on the Role of CA‐125 Measurement in Follow-Up of Epithelial Ovarian Cancer (2012) (10)
- ENGOT-OV44/FIRST study: A randomized, double-blind, adaptive, phase III study of platinum-based therapy with dostarlimab (TSR-042) + niraparib versus standard-of-care (SOC) platinum-based therapy as first-line treatment of stage 3/4 non-mucinous epithelial ovarian cancer (OC). (2019) (10)
- Human Papillomavirus DNA Presence in Pelvic Lymph Nodes in Cervical Cancer (2009) (9)
- Training in Bowel and Upper Abdominal Surgery in Gynaecological Oncology: European Society of Gynecological Oncology (ESGO) Statement (2011) (9)
- Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial. (2021) (9)
- ENGOT-OV43/KEYLYNK-001: A phase III, randomized, double-blind, active- and placebo-controlled study of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA-nonmutated advanced epithelial ovarian cancer. (2019) (9)
- Comparison of corticoid substitution versus combined oral contraception administration in the treatment of non-classic adrenal hyperplasia: A prospective study (2009) (9)
- What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries (2018) (9)
- 518O Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation (2022) (9)
- Impact of sentinel lymph node frozen section evaluation to avoid combined treatment in early-stage cervical cancer (2020) (9)
- Tisotumab vedotin (TV) + pembrolizumab (pembro) in first-line (1L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT Cx8/GOG 3024/innovaTV 205. (2022) (9)
- [Abdominal radical trachelectomy--technique and experience]. (2005) (9)
- A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial (2014) (9)
- Ultrasound characteristics of a symptomatic and asymptomatic lymphocele after pelvic and/or paraaortic lymphadenectomy. (2019) (8)
- Pathologic Protocols for Sentinel Lymph Nodes Ultrastaging in Cervical Cancer. (2019) (8)
- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. (2022) (8)
- OC132: The role of ultrasound in prediction of optimal vs. suboptimal cytoreductive surgery in advanced ovarian cancers (2008) (8)
- Abortions and contraception use among Czech and Romanian women: comparison of representative national studies. (2011) (7)
- Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: cross-over designed study. (2006) (7)
- Reinstatement of serum pregnanolone isomers and progesterone during alcohol detoxification therapy in premenopausal women. (2005) (7)
- Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis. (2022) (7)
- Outcomes of pregnant patients with Pap smears classified as atypical glandular cells (2012) (7)
- Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician’s choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33) (2021) (7)
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours (2021) (7)
- [The factor V Leiden mutation in users of hormonal contraceptives]. (2000) (7)
- The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines). (2019) (7)
- VP2-2022: Prospective double-blind, randomized phase III ENGOT-EN5/GOG-3055/SIENDO study of oral selinexor/placebo as maintenance therapy after first-line chemotherapy for advanced or recurrent endometrial cancer (2022) (7)
- Novel complex genomic rearrangement of the BRCA1 gene. (2008) (7)
- Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators (2021) (7)
- An autologous dendritic cell vaccine promotes anticancer immunity in ovarian cancer patients with low mutational burden and cold tumors. (2022) (7)
- ENGOT-OV44/FIRST study: a randomized, double-blind, adaptive, phase III study of standard of care (SOC) platinum-based therapy ± dostarlimab followed by niraparib ± dostarlimab maintenance as first-line (1L) treatment of stage 3 or 4 ovarian cancer (OC). (2020) (7)
- Surgical principles in gynecologic oncology (2013) (7)
- Post-recurrence survival in patients with cervical cancer. (2021) (7)
- [Fetal fibronectin in cervico-vaginal secretions--an indicator of incipient premature labor using a membrane immunoassay]. (1995) (7)
- Comparison of Plasma Osteopontin Levels between Patients with Borderline Ovarian Tumours and Serous Ovarian Carcinoma. (2016) (7)
- Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION interim analysis. (2020) (7)
- Sensitivity of Follow-Up Methods in Patients After Fertility-Sparing Surgery for Cervical Cancers (2016) (7)
- [Rational laparoscopic intervention in laparoscopically-assisted vaginal hysterectomy (LAVH): prospective study]. (1999) (7)
- A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets (2022) (6)
- Oncological outcome of surgical management in patients with recurrent uterine cancer—a multicenter retrospective cohort study—CEEGOG EX01 Trial (2019) (6)
- Clinical impact of low-volume lymph node metastases in early-stage cervical cancer: A comprehensive meta-analysis. (2021) (6)
- Cancer incidence and mortality in the Czech Republic. (2014) (6)
- High-risk human papillomavirus DNA in paraaortic lymph nodes in advanced stages of cervical carcinoma. (2011) (6)
- Subgroup analysis of rucaparib versus chemotherapy as treatment for BRCA-mutated, advanced, relapsed ovarian carcinoma: Effect of platinum sensitivity in the randomized, phase 3 study ARIEL4. (2021) (6)
- Management of pregnancy after fertility‐sparing surgery for cervical cancer (2020) (6)
- Early Learning Curve in the Assessment of Deep Pelvic Endometriosis for Ultrasound and Magnetic Resonance Imaging (2020) (6)
- Primary Synovial Sarcoma of the Uterus (2012) (6)
- Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey (2019) (6)
- Sister Society Meeting on Global Education Development and Collaboration: Meeting Report. (2016) (6)
- Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial. (2017) (6)
- Prospective Evaluation of Ultrasound Accuracy in the Detection of Pelvic Carcinomatosis in Patients with Ovarian Cancer. (2016) (6)
- 33 Olaparib monotherapy versus (VS) chemotherapy for germline BRCA-mutated (GBRCAM) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (PTS): phase III solo3 trial (2019) (5)
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial (2022) (5)
- European Surgical Education and Training in Gynecologic Oncology: The impact of an Accredited Fellowship (2017) (5)
- Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines (2022) (5)
- Hysteroscopic management of displaced levonorgestrel‐releasing intrauterine system (2013) (5)
- CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16) (2022) (5)
- An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3β-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome (2000) (5)
- Chromosomal rearrangements and their relations to histopathological and clinical parameters in epithelial ovarian cancer. (2008) (5)
- Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery (2020) (5)
- Perspectives, Fears and Expectations of Patients with Gynaecological Cancers During the COVID-19 Pandemic: A Pan-European Study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) (2020) (5)
- Imaging in gynecological disease (19): clinical and ultrasound features of extragastrointestinal stromal tumors (eGIST) (2020) (5)
- Central Pathology Review in SENTIX, a Prospective Observational International Study on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (ENGOT-CX2) (2020) (5)
- Factors influencing decisions about surgical treatment of cervical precancerous lesions (2014) (5)
- [Use of transrectal ultrasound and magnetic resonance imaging in the staging of early-stage cervical cancer]. (2009) (5)
- Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX. (2021) (5)
- Management of patients with intermediate-risk early stage cervical cancer (2020) (5)
- Sister Society Meeting on Global Education Development and Collaboration: Meeting Report (2016) (4)
- Umbilication Is a Strong Predictor of High-Grade Cervical Intraepithelial Neoplasia (2013) (4)
- 1Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase III study (2021) (4)
- Application of International Deep Endometriosis Analysis (IDEA) group consensus in preoperative ultrasound and magnetic resonance imaging of deep pelvic endometriosis (2019) (4)
- AGO-OVAR 28/ENGOT-ov57: Niraparib versus niraparib in combination with bevacizumab in patients with carboplatin-taxane based chemotherapy in advanced ovarian cancer—A multicenter, randomized, phase III trial. (2022) (4)
- [Effect of insulin in polycystic ovary syndrome]. (2002) (4)
- SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer (2022) (4)
- Comparative analysis of loss of heterozygosity and expression profi le in normal tissue, DCIS and invasive breast cancer (2011) (4)
- Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock (2022) (4)
- Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (2018) (4)
- Multiple ovarian biopsy in the treatment of women with polycystic ovary syndrome (PCOS). (2000) (4)
- Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial. (2018) (4)
- A prospective evaluation of ultrasound accuracy in the prediction of rectosigmoid infiltration in patients with epithelial ovarian cancer (2016) (4)
- Myxoid mixed low-grade endometrial stromal sarcoma and smooth muscle tumor of the uterus. Case report. (2012) (4)
- Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey (2020) (4)
- OC14.06: Preoperative staging of advanced ovarian cancer comparison between ultrasound, CT and WB‐DWI/MRI (2017) (3)
- Are we better off using multiple endometriosis classifications in imaging and surgery than settle for one universal less than perfect protocol? Review of staging systems in ultrasound, magnetic resonance and surgery. (2021) (3)
- An international series on abdominal trachelectomy: 101 patients and 28 pregnancies (2012) (3)
- [Prediction of increased levels of androgen in women with acne vulgaris using ultrasound and clinical parameters]. (1999) (3)
- Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole‐body diffusion‐weighted MRI (ISAAC study) (2022) (3)
- [Laparoscopic lymph-node dissection in gynecological surgery]. (2012) (3)
- Prognostic signi fi cance of low volume sentinel lymph node disease in early-stage cervical cancer ☆ (2011) (3)
- Pelvic Exenteration for Gynecologic Cancers (2018) (3)
- The WID‐qEC test: Performance in a hospital‐based cohort and feasibility to detect endometrial and cervical cancers (2022) (3)
- Correction: The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer (2012) (3)
- [Hysteroscopic resection of submucosal myomas in abnormal uterine bleeding: results of a 4-year prospective study]. (1999) (3)
- European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma (2021) (3)
- Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) + pembrolizumab (pembro) + carboplatin (carbo) ± bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC). (2022) (3)
- A comprehensive analysis of the expression, epigenetic and genetic changes of HNF1B and ECI2 in 122 cases of high-grade serous ovarian carcinoma (2021) (3)
- Factors affecting preoperative local staging of endometrialcancer (2013) (3)
- KEYNOTE-C93/GOG-3064/ENGOT-en15: A phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma. (2022) (3)
- Radical Hysterectomy in Cervical Cancer (2015) (2)
- Laterally extended endopelvic resection with external iliac vessels resection and crossover ileofemoral bypass (2019) (2)
- Maintenance olaparib in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by somatic (s) or germline (g) BRCA and other homologous recombination repair (HRR) gene mutation status: Overall survival (OS) results from the ORZORA study. (2022) (2)
- Utility and Actual Use of European and Spanish Guidelines on the Management of Endometrial Cancer Among Gynecologic Oncologists in Spain (2017) (2)
- Extended pelvic resection for gynecological malignancies: A review of out-of-the-box surgery. (2022) (2)
- ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA¬-nonmutated advanced epithelial ovarian cancer (2019) (2)
- [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome]. (2001) (2)
- [Recommendations for the levonorgestrel intrauterine system (LNG-IUS). 2006]. (2007) (2)
- Preoperative staging of advanced ovarian cancer: comparison between ultrasound, CT and WB-DWI/MRI (ISAAC). (2021) (2)
- ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer. (2021) (2)
- 531P Maintenance olaparib monotherapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSR OC) without a germline BRCA1/BRCA2 mutation (non-gBRCAm): Final overall survival (OS) results from the OPINION trial (2022) (2)
- P54 Comparison of clinical and ultrasound characteristics in low and high grade serous cancer (2019) (2)
- Exploratory Biochemical Data Analysis: a Comparison of Two Sample Means and Diagnostic Displays (2001) (2)
- Determining post-operative morbidity and mortality following gynecological oncology surgery: protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative—GO SOAR) (2021) (2)
- Quality of life after extended pelvic exenterations. (2022) (2)
- Contraceptive behaviour of Czech and Romanian women: comparison of representative national samples. (2011) (2)
- [Contribution of neoadjuvant chemotherapy for operability of cancers of the uterine cervix]. (2007) (2)
- The WID‐EC test for the detection and risk prediction of endometrial cancer (2022) (2)
- Ten years of live surgical broadcast at Charité-MAYO conferences (2010–2019): a systematic evaluation of the surgical outcome (2022) (2)
- Validation of sentinel lymph biopsy in patients with early stage vulvar cancer: A prospective trial of 1552 women (GROINSS-V II/GOG270) (2020) (2)
- Tailoring surgical treatment of cervical precancerosis. (2014) (2)
- DNA methylation signatures to predict the cervicovaginal microbiome status (2020) (2)
- Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe. (2022) (2)
- Transrectal ultrasound (TRUS) and MRI in staging of early cervical cancer (2007) (2)
- Letter to the editor, Reply to: Cecile Colpaert et al.: Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? (2019) (2)
- Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO) (2022) (2)
- [Inactivation of BRCA1, BRCA2 and p53 genes in sporadic ovarian cancer]. (2008) (2)
- [Ultrasound-guided intervention in the treatment of abdomino-pelvic advanced tumors]. (2009) (2)
- Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with recurrent epithelial ovarian carcinoma (EOC) after complete response (CR) to 1st-line platinum (Pt)-based ct: Primary analysis of a phase 2, open-label, randomized, multicenter trial. (2018) (2)
- Dendritic cell-based immunotherapy (DCVAC/OvCa) with chemotherapy in patients with platinum-sensitive, relapsed, epithelial ovarian carcinoma: Survival analysis of a phase II, open-label, randomized, multicenter trial (study SOV02) (2019) (2)
- Radiotherapy as an alternative treatment for inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: Results of GROINSS-V II (2020) (2)
- Olaparib maintenance therapy in patients (pts) with platinum-sensitive relapsed (PSR) ovarian cancer (OC) and stable disease (SD) following platinum-based chemotherapy. (2018) (2)
- ORZORA: Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status (2021) (2)
- [Pharmacology of progestins used in oral hormonal contraceptive preparations]. (2000) (2)
- Accuracy of ultrasound in prediction of rectosigmoid infiltration in epithelial ovarian cancer (2017) (2)
- OC129: Role of ultrasound in guiding of surgery radicality in cervical cancer management (2008) (2)
- 184 UPLIFT (ENGOT-ov67/GOG-3048) a pivotal cohort of upifitamab rilsodotin, a NaPi2b-directed ADC in platinum-resistant ovarian cancer (2021) (2)
- SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer (2022) (2)
- [Endometrial ablation: prospective 3-year follow-up study]. (1999) (2)
- SIENDO/ENGOT-EN5/GOG-3055: A randomized phase 3 trial of maintenance selinexor versus placebo after combination platinum-based chemotherapy in advanced or recurrent endometrial cancer. (2021) (2)
- [The rational preoperative diagnosis of ovarian tumors - imaging techniques and tumor biomarkers (review)]. (2012) (2)
- 950 Sensitivity and false negativity of SLN frozen sectionhistological evaluation in the sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063) (2021) (1)
- [Initial experience with the Versapoint bipolar electrode in hysteroscopic tissue vaporization]. (2000) (1)
- 2022-RA-689-ESGO Fertility-sparing treatment in patients with IB1 cervical cancer – results of the international multicentre retrospective FERTISS study (ENGOT Cx14; CEEGOG Cx-03) (2022) (1)
- Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees. (2017) (1)
- Low-density lipoprotein receptor-related protein-5 C/T polymorphism in exon 18 is associated with C peptide and proinsulin levels in control women and patients with polycystic ovary syndrome. (2008) (1)
- 20th International Meeting of the European Society of Gynaecological Oncology (2017) (1)
- 966 SENTIX – accuracy of preoperative local staging in the sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063) (2021) (1)
- Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer. (2019) (1)
- 254TiP ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer (2020) (1)
- [Recommendations for hormone replacement therapy in perimenopause and postmenopause]. (2003) (1)
- 22 Open vs. minimally invasive radical trachelectomy in early stage cervical cancer: international multicenter irta study results (2019) (1)
- [Clinical study of a triphasic contraceptive preparation (Norgestimate 180/215/250 micrograms + ethinylestradiol 35 micrograms) in a population of Czech women]. (1999) (1)
- Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees (2017) (1)
- TP004/#1457 Trial in progress of engot-CX8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer (2022) (1)
- An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome. (2000) (1)
- Olaparib maintenance monotherapy for non-germline BRCA1/2-mutated (non-gBRCAm) platinum-sensitive relapsed ovarian cancer (PSR OC) patients (pts): Phase IIIb OPINION primary analysis. (1)
- [Premature ovarian failure syndrome]. (2000) (1)
- The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership (2015) (1)
- Are patients and physicians willing to accept less-radical procedures for cervical cancer? (2018) (1)
- ENGOT-ov43/keylynk-001: A phase III, placebo- and active-controlled trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of advanced BRCA-nonmutated epithelial ovarian cancer (2020) (1)
- OC06.04: Agreement of 2D and 3D ultrasound and magnetic resonance imaging in the assessment of rectosigmoid infiltration in primary or recurrent ovarian cancer† (2014) (1)
- EP334 SENTIX – sentinel lymph nodes in patients with cervical cancer: SLN detection and the false negative rate of SLN frozen section (CEEGOG-CX01; ENGOT-CX2; NCT02494063) (2019) (1)
- A single arm, phase 2, multicenter, international trial of tisotumab vedotin (HuMax-TF-ADC) in previously treated, recurrent or metastatic cervical cancer. (2018) (1)
- 898 The impact of micrometastases in cervical cancer patients – a retrospective study of the SCCAN (Surveillance in Cervical CANcer) project (2021) (1)
- [Late (non-classic) adrenal hyperplasia]. (2007) (1)
- [Radical parametrectomy in women with invasive cervix cancer after previous simple hysterectomy]. (2006) (1)
- 816TiP Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs physician’s choice CHEmotherapy in recurrent ovarian, fallopian tube or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33) (2021) (1)
- [Reconstruction procedures following pelvic exenterations]. (2005) (1)
- OP09.06: The association of changes in cervical cancerechogenicity and vascularization with treatment effect of neoadjuvant chemotherapy (2014) (1)
- [The role apoptosis in the extent of endometriosis and its clinical symptomatology]. (2003) (1)
- OP20.02: Sonographic features of inguinal lymph nodes in vulvar cancer (2017) (1)
- Classification system for pelvic lymphadenectomy in cervical cancer (2010) (1)
- Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer (2007) (1)
- P154 Tumor treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: phase 3 INNOVATE/ENGOT-ov50 study (2019) (1)
- Tumour treating fields (200 kHz) concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: Phase III INNOVATE-3/ENGOT-ov50 study (2019) (1)
- Patient-reported outcomes in the randomized phase III IMagyn050/GOG3015/ENGOT-ov39 trial evaluating atezolizumab (atezo) with carboplatin/paclitaxel/bevacizumab for newly diagnosed ovarian cancer (2021) (1)
- 806O Radical hysterectomy in cervical cancer patients with intraoperatively detected positive lymph node: ABRAX multicentric retrospective cohort study (ENGOT-Cx3/CEEGOG CX2) (2020) (1)
- Correction to: Correction to: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer (2018) (1)
- ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023* (2023) (1)
- Polycystic Ovary Syndrome: Implications for Cardiovascular, Endometrial, and Breast Disease (2004) (1)
- OC12.03: Comparison of clinical and ultrasound characteristics in low‐ and high‐grade serous cancer (2019) (1)
- Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTISS retrospective multicenter study. (2022) (1)
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma (2023) (1)
- [Informed consent for factor V Leiden mutation screening before recommending use of combined hormonal contraceptives or hormone replacement therapy ]. (2003) (1)
- 2022-RA-891-ESGO Preoperative assessment of non-resectability in patients with ovarian cancer using imaging (ISAAC study) – an interim analysis (2022) (1)
- EPV255/#120 Tisotumab vedotin vs investigator’s choice chemotherapy in second- or third-line recurrent or metastatic cervical cancer (innovatv 301/ENGOT-CX12/GOG-3057, trial in progress) (2021) (1)
- Modified rectus abdominis myoperitoneal flap for pelvic floor reconstruction. (2019) (1)
- 526MO Pathological assessment of sentinel lymph node in early-stage cervical cancer: Results from the prospective SENTIX trial (CEEGOG-CX01; ENGOT-CX2) (2022) (1)
- LB001/#1731 Late-breaking abstract presentation: overall survival by number of prior lines of chemotherapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer receiving olaparib treatment or non-platinum chemotherapy in SOLO3 (2022) (1)
- OC24.05: The role of ultrasound in planning fertility sparing surgery and individual treatment in early stage cervical cancer (2012) (1)
- [Hereditary ovarian cancer]. (2006) (1)
- [Importance of chromosomal changes correlated to prognostic factors in ovarian and cervical malignant tumors]. (2008) (1)
- OC06.02: Diagnostic performance of ultrasound in the assessment of parametrial involvement before surgery in cervical cancer patients (diagnostic accuracy study) (2020) (1)
- Yolk Sac Tumor of the Omentum: A Case Report and Literature Review (2022) (1)
- OC23.01: Role of ultrasound in the referral of young patients with cervical cancer for fertility sparing surgery (2009) (1)
- Autologous dendritic cell vaccination (DCVAC/OvCa) added to standard of care therapy in three open-label randomized phase 2 studies in women with advanced stage ovarian cancer (OC). (2014) (1)
- Believable or not believable MRAM (2017) (1)
- 2022-RA-908-ESGO The importance of pathological ultrastaging for sentinel lymph nodebiopsy in cervical cancer, the final outcome of the Sentix study (CEEGOG-CX01; ENGOT-CX2; NCT02494063) (2022) (1)
- OC08.01: Preoperative staging of ovarian cancer: comparison between ultrasound, CT and WB‐DWI/MRI (2018) (1)
- Early-stage intermediate-risk—the group with the most heterogenous management among patients with cervical cancer (2022) (1)
- OC06.03: Terms, definitions and measurements to describe the sonographic features of lymph nodes: a consensus opinion from the Vulvar International Tumor Analysis (VITA) group (2020) (1)
- [Borderline ovarian tumors--10-year clinical series and literature review]. (2004) (1)
- 2022-RA-959-ESGO Pelvic sentinel lymph nodedistribution; the final outcome of the Sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063) (2022) (1)
- Dendritic cell vaccine (DCVAC) combined with chemotherapy (CMT) in patients with newly diagnosed epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Biomarker exploratory analysis of a phase 2, open-label, randomized, multicenter trial. (2021) (1)
- Ovarian Cancer Screening There May Be Light at the End of the Tunnel? (2016) (1)
- 960 The annual recurrence risk model for tailored surveillance strategy in cervical cancer patients (2021) (1)
- [Long-term follow-up after complete treatment of peritoneal endometriosis with the CO2 laser]. (2003) (1)
- 358 Phase 3 trial of tumor treating fields concomitant with weekly paclitaxel for platinum-resistant ovarian cancer: ENGOT-ov50/GOG-329/INNOVATE-3 (2020) (0)
- 2022-RA-1638-ESGO Randomized phase III trial on Niraparib-TSR-042 (dostarlimab) versus physician’s choice in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33) (2022) (0)
- [Guideline recommendations for gestagen contraception. 2006]. (2006) (0)
- Relationships of circulating pregna nolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy (2007) (0)
- BMD and biochemical markers of bone turnover in adolescent girls on oral contraceptives with different estrogen content (2009) (0)
- 293 Quality of training in cervical cancer surgery: a survey from the European network of young gynaecologic oncologists (ENYGO) (2021) (0)
- Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer. (2023) (0)
- Tisotumab vedotin versus investigator’s choice chemotherapy in second- or third-line recurrent or metastatic cervical cancer (innovaTV 301/ENGOT-cx12/GOG 3057, trial in progress). (2021) (0)
- [Ductal approaches in mammary diagnostics]. (2007) (0)
- OP29.03: Permanent peritoneal catheter introduced under ultrasound guidance as a palliative derivation of torpid ascites (2012) (0)
- OC07.06: Ultrasound accuracy in prediction of pelvic carcinomatosis and rectosigmoid involvement in advanced ovarian cancer patients (2015) (0)
- PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study (2023) (0)
- [The effect of hormonal contraception on liver function]. (1997) (0)
- 133 Accuracy of transvaginal/transrectal ultrasound in preoperative pelvic lymph node assessment in cervical cancer patients (2021) (0)
- OC17.05: Ultrasound accuracy in prediction of pelvic carcinomatosis in advanced ovarian cancer patients (2013) (0)
- 985 Post-Operative Morbidity & Mortality following Gynaecological Oncology Surgery: Protocol for a Global Prospective Cohort Study (GO SOAR1) (2021) (0)
- DNA HR HPV in Cervical Cancer Tissue, in Sentinel and Other Pelvic Lymph Nodes - A Correlation with Histopathological and Imunohistochemical Results (2008) (0)
- [Conservative treatment of dysfunctional uterine bleeding]. (2001) (0)
- Abstract A008: TP53 field defects in uterine fluid are associated with ovarian cancer risk (2022) (0)
- [Ultrasound-guided minimally invasive interventions in gynecologic oncology]. (2011) (0)
- [Survey of contraceptive behaviour and attitude of Czech women towards different types of contraception]. (2010) (0)
- [Attitudes of Czech women toward induced abortions]. (2009) (0)
- [Liver function tests during administration of triphasic contraceptives containing Norgestimate]. (2000) (0)
- LBA30 Phase III ATALANTE/ov29 trial: Atezolizumab (Atz) versus placebo with platinum-based chemotherapy (Cx) plus bevacizumab (bev) in patients (pts) with platinum-sensitive relapse (PSR) of epithelial ovarian cancer (OC) (2022) (0)
- SENTIX – Sentinel lymph node in patients with cervical cancer: time to voiding recovery after surgery (CEEGOG-CX01; ENGOT-CX2; NCT02494063) (2019) (0)
- A UTERINE-CONFINED PHASE 3 STUDY OF PEMBROLIZUMAB OR PLACEBO IN COMBINATION WITH ADJUVANT CHEMOTHERAPY WITH/WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED HIGH-RISK (2022) (0)
- 2022-RA-1579-ESGO RACE: retrospective study on rare types of cervical cancer- CEEGOG CX-06 (2022) (0)
- Recommendation for prescription of postcoital contraception (2001) (0)
- OC06.01: *Comparison of pre‐ and postmenopausal endometrial cancer regarding sonographic features and clinical characteristics: results from the IETA‐4 cohort (2020) (0)
- EPV036/#142 European network for gynaecological oncological trial (ENGOT)-CX11/gynecologic oncology group (GOG) 3047/keynote-A18: phase 3 trial of pembrolizumab plus chemoradiotherapy in high-risk locally advanced cervical cancer (2021) (0)
- 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer (2022) (0)
- [Molecular characterization of epithelial ovarian borderline tumors with respect to clinical management and prognosis]. (2009) (0)
- P08.01: Clear cell adenofibroma/fibrocarcinoma of the ovary: ultrasound, macroscopic and histopathologic findings. A case report (2005) (0)
- Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project. (2022) (0)
- [Exenteration procedures in the pelvis]. (2005) (0)
- Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer. (2023) (0)
- O009/#786 Rucaparib vs chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious brca mutation: efficacy and safety from ariel4, a randomized phase 3 study (2021) (0)
- 2022-RA-1392-ESGO Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: interim results of ENGOT Cx8/GOG-3024/innovaTV205 (2022) (0)
- 1056 Live surgical broadcast and patient outcome – 10 years of experience from the international Charité MAYO conferences 2010–2019 (2021) (0)
- OC167: Ultrasound‐guided tru‐cut biopsy in the diagnosis and management of inoperable pelvic tumors (2006) (0)
- OC20.07: Early learning curve in the assessment of deep infiltrating pelvic endometriosis when using ultrasound and magnetic resonance imaging (2019) (0)
- 959 Challenges in lower limb lymphoedema assessment based on limb volume change: lessons learnt from the SENTIX prospective multicentre study (2021) (0)
- OC24.04: Intra‐operative ultrasound in fertility sparing procedures for cervical cancer (2012) (0)
- Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline? (2023) (0)
- [Prenatal diagnosis of spina bifida and abdominal wall defects]. (1995) (0)
- OP31.06: Ultrasound characteristics of non‐genital abdomino‐pelvic tumors (2010) (0)
- [Results from the Registry of Complications in Users of Hormonal Contraception in 1998]. (2000) (0)
- 28th World Congress on Ultrasound in Obstetrics and Gynecology, 20–24 October 2018, Singapore: presentations and awards (2018) (0)
- LAPAROSCOPIC ABDOMINAL RADICAL TRACHELECTOMY (PIVER III) – CASE REPORT (2004) (0)
- Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation (2022) (0)
- 0660: The Ultrasound-Guided Tru-Cut Biopsy in the Diagnosis and Management of Inoperable Pelvic Tumors (2006) (0)
- [Complications in gynecologic endoscopy--a 7-year retrospective clinical study]. (1999) (0)
- 2) Sentinel lymph node concept in the management of cervical cancer(1. Oncology,International Seminar) (2015) (0)
- EP34.02: Clinical and ultrasound features of extra gastrointestinal stromal tumours (eGIST) (2019) (0)
- UPLIFT (ENGOT-ov67/GOG-3048) a pivotal cohort of upifitamab rilsodotin (XMT-1536; UpRi), a NaPi2b-directed dolaflexin antibody drug conjugate (ADC) in platinum-resistant ovarian cancer (585) (2022) (0)
- A Novel Perspective of Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer (2016) (0)
- [Recommendations for prescribing combined oral contraceptives]. (2000) (0)
- OP09.01: The diagnostic accuracy of ultrasound in assessment of myometrial and cervical invasion in endometrial cancer: subjective assessment vs. objective techniques (2014) (0)
- OC24.01: Early stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound in a preoperative staging, verified by pathological results: the results of an European multicentre trial (2012) (0)
- ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023. (2023) (0)
- Gynecological lesions in hereditary cancer predisposition syndromes. (2021) (0)
- OC08.03: Subjective and objective strategies to assess myometrial invasion and cervical stromal invasion in women with endometrial cancer from the IETA cohort (2018) (0)
- 8030 Prospective validation of a predictive score for complete tumor resection in recurrent ovarian cancer (ROC): an intergroup study of AGO kommission OVAR, AGO-OVAR, AGO Austria, MITO and NOGGO (2009) (0)
- OC15.02: *Deep endometriosis assessment on ultrasound and MRI as defined by international deep endometriosis analysis (IDEA) group (diagnostic accuracy study) (2018) (0)
- 942 Survival after recurrence in early-stage cervical cancer patients (2021) (0)
- [Recommendations for prescribing postcoital contraceptives]. (2001) (0)
- [Analyses of LOH and expression in healthy gland, DCIS and invasive breast cancer gland]. (2009) (0)
- OC01.06: Ultrasound accuracy in prediction of rectosigmoid involvement in advanced ovarian cancer patients (2012) (0)
- DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test (2022) (0)
- Diagnostic performance of ultrasound in the assessment of parametrial involvement before surgery in cervical cancer patients (diagnostic accuracy study) (2019) (0)
- Terminology and classification system of radical hysterectomy (2012) (0)
- 2022-RA-909-ESGO AGO-OVAR 28/ENGOT-ov57: niraparib vs niraparib in combination with bevacizumab in patients with carboplatin-taxane based chemotherapy in advanced ovarian cancer (a multicentre randomised phase III trial) (2022) (0)
- DNA methylation signatures to predict the cervicovaginal microbiome status (2020) (0)
- 2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis (2022) (0)
- [Transabdominal ultrasound examination in gynecology]. (2011) (0)
- OC10.04: The role of ultrasound in lymph node staging in vulvar cancer (2016) (0)
- Imaging in gynecological disease: clinical and ultrasound characteristics of benign retroperitoneal pelvic nerve sheath tumors. (2023) (0)
- PARP inhibitors in ovarian cancer (2015) (0)
- P26 Micrometastasis in sentinel lymph nodes is a significant negative prognostic marker in early-stage cervical cancer (2019) (0)
- OC23.06: Adequacy and safety of ultrasound guided tru‐cut biopsy in the management of abdomino‐pelvic tumors (2009) (0)
- [Antiemetics in gynecologic oncology]. (2003) (0)
- Oncological outcomes of patients with cervical cancer after fertility-sparing treatment – fertiss retrospective multicenter trial (2022) (0)
- OP24.07: Morphological and vascular ultrasound characteristics of pelvic masses of non‐gynecological origin (2011) (0)
- TP016/#1442 Keynote-C93/GOG-3064/ENGOT-EN15: phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma (2022) (0)
- OC12.06: Validation of objective measurements to predict myometrial or cervical stromal invasion and prediction models to predict high‐risk endometrial cancer (2018) (0)
- Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer (2021) (0)
- P18 Tumor free distance is the best predictive marker in patients with early-stage cervical cancer treated by primary surgery (2019) (0)
- [Pelvic exenteration]. (2005) (0)
- Sentinel lymph node mapping in cervical cancer (2022) (0)
- Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial. (2023) (0)
- [Initial experience in exenteration interventions in the pelvis]. (2004) (0)
- Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock (2022) (0)
- Reconstruction of defect after radical vulvectomy by the use of four-flap local transfer--a case report. (2009) (0)
- 12P Any size of lymph node metastasis should be considered N1 in patients with cervical cancer (2022) (0)
- The polycystic ovary syndrome: the first 150 years of study (2022) (0)
- Intercellular adhesion molecule 1, ICAM-1, in polycystic ovary syndrome: relationship to insulin resistance or obesity (2005) (0)
- TP023/#1560 A phase 3, randomized, double-blind, placebo/paclitaxel-controlled study of batiraxcept in combination with weekly paclitaxel in patients with platinum-resistant recurrent ovarian cancer (GOG-3059/ENGOT OV-66) (2022) (0)
- Insulin sensitivity during treatment of PCOS women with oral contraceptives containing norgestimate (2000) (0)
- O286 Comparison of corticoid substitution versus combined oral contraception administration in the treatment of nonclassic adrenal hyperplasia (NCAH) (2009) (0)
- [Molecular biology of preinvasive and invasive breast tumors]. (2008) (0)
- OC27.01: Ultrasound diagnosis of extragenital abdominopelvic tumors (2009) (0)
- 2022-RA-426-ESGO Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical impact in patients with cervical cancer: subgroup analysis of the SCCAN project (2022) (0)
- Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study. (2023) (0)
- OP07.03: Ultrasound characteristics of a symptomatic and asymptomatic lymphocele after pelvic and/or paraaortic lymphadenectomy (2015) (0)
- [Hyperandrogenic syndrome (polycystic ovary syndrome)--diagnostic criteria, differential diagnosis, clinical signs and laboratory findings (symptomatology), late risks]. (2000) (0)
- P36 SENTIX – a prospective cohort international study on sentinel lymph node biopsy without pelvic lymph node dissection in cervical cancer patients: central quality control of SLN pathological assessment (CEEGOG-CX01; ENGOT-CX2; NCT02494063) (2019) (0)
- A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors (2023) (0)
- EPV107/#258 ENGOT-EN11/GOG-3053/KEYNOTE-B21: phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer (2021) (0)
- [Possibilities of increased radicality in pelvic exenteration]. (2005) (0)
- Prevalence of apoptosis in endometriotic lesions (2002) (0)
- [Knowledge of Czech and Romanian women about STIs. Representative survey]. (2009) (0)
- [Contribution of sentinel lymph-node biopsy to treatment of locally advanced stages of cervical cancers]. (2018) (0)
- 2022-RA-883-ESGO Rare Cancers in Gynecologic Oncology, ENGOT initiative for a European Registry (2022) (0)
- 991 Fertility sparing surgery in cervical cancer patients outside controlled trials – a multicenter retrospective cohort trial (CEEGOG Cx-03; ENGOT-CX14) (2021) (0)
- 114 Lower-limb lymphedema after sentinel lymph node biopsy in cervical cancer patients (2021) (0)
- Identification of novel HNF1B mRNA splicing variants and their qualitative and semi-quantitative profile in selected healthy and tumour tissues (2020) (0)
- OC23.07: Analysis of factors influencing tru‐cut biopsy sample adequacy in management of abdomino‐pelvic masses (2009) (0)
- 261 ENGOT-cx11/GOG 3047/KEYNOTE-A18: phase 3 randomized study of pembrolizumab + chemoradiotherapy for high-risk locally advanced cervical cancer (2021) (0)
- [Prediction of the effect of a triphasic contraceptive agent with norgestimate on acne]. (2000) (0)
- [Glandular premalignant lesions of the uterine cervix]. (2006) (0)
- Abstracts of the 26th World Congress on Ultrasound in Obstetrics and Gynecology, Rome, Italy, 24-28 September 2016. (2016) (0)
- 2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer (2022) (0)
- Primary retroperitoneal nodal endometrioid carcinoma associated with Lynch syndrome: A case report (2023) (0)
- Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories. (2023) (0)
- 185 ENGOT-en11/GOG-3053/KEYNOTE-B21: phase 3 study of pembrolizumab or placebo + adjuvant chemotherapy ± radiotherapy for high-risk endometrial cancer (2021) (0)
- EP447 Clinical and ultrasound features of extra gastrointestinal stromal tumors (eGIST) (2019) (0)
- The effect of combination therapy of metformin with combined oral contraceptives (COC) versus COC monotherapy in PCOS patients: a randomized study (2003) (0)
- Challenges in lower limb lymphoedema assessment based on limb volume change: Lessons learnt from the SENTIX prospective multicentre study. (2021) (0)
- Abdominal procedures in gynaecological oncology (2008) (0)
- UCP1 (A-3826G) and PPARG2 (Pro12Ala) polymorphisms in women with polycystic ovary syndrome (2005) (0)
- [Conservative treatment of endometriosis]. (1998) (0)
- 164 ENGOT-cx11/GOG 3047/KEYNOTE-A18: a phase 3, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer (2020) (0)
- 744 Terms and definitions to describe sonographic features of lymph nodes: consensus opinion from the vulvar international tumor analysis (VITA) group (2021) (0)
- Preoperative staging of advanced ovarian cancer: comparison between ultrasound, computed tomography (CT) and whole-body MRI with diffusion-weighted sequence (WB-DWI/MRI) (2019) (0)
- Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy (2022) (0)
- Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiative (2022) (0)
- Oncological Outcome After Completing or Abandoning (Radical) Hysterectomy in Patients With Cervical Cancer and Intraoperative Detection of LN Positivity (2019) (0)
- [Endometrial ablation]. (1998) (0)
- [Can hormonal contraceptives affect plasma levels of IGF-1 and IGFBP-1 in slim women with polycystic ovary syndrome?]. (2001) (0)
- OP14.03: Prevalence of lymphocysts after pelvic and paraaortic lymphadenectomy and treatment with mini invasive ultrasound-guided drainage (2013) (0)
- [Recommendations for diagnosis and therapy of premenstrual syndrome (PMS). 2006]. (2006) (0)
- 47P Quality of life after extended pelvic exenterations (2022) (0)
- [Proteomics and its importance for gynecological oncology]. (2004) (0)
- 2022-RA-1301-ESGO The impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: a sub-analysis of the SCCAN study (2022) (0)
- Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review (2023) (0)
- [Hereditary susceptibility to endometrial cancer]. (2011) (0)
- [Recommendations for hormonal therapy and substitution]. (2006) (0)
- With Thanks to the International Journal of Gynecological Cancer: Reviewers of 2011 (2011) (0)
- 2022-RA-1257-ESGO MILACC Study: Is the manipulation with LN containing undetected micrometastases the underlying cause of higher rate of local recurrences in the LACC trial? (2022) (0)
- [Sexual morbidity after surgery for gynaecologic cancer]. (2010) (0)
- [Continuous use--the important trend of combined hormonal contraception]. (2006) (0)
- A new blood test uses DNA methylation to detect and predict the spread of breast cancer (2020) (0)
- Physiological Relevance of Pregnanolone Isomers and Their Polar Conjugates with Respect to the Gender, Menstrual Cycle and Pregnancy (2011) (0)
- A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival (2014) (0)
- Consensus Statement on pre- operative diagnosis of ovarian tumors (2021) (0)
- The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer (2017) (0)
- Perceptions, expectations, and experiences of gynecological cancer patients [Recurso electrónico] : a pan-European ESGO-ENGAGe survey / Esra Urkmez ... [et al.]. (2020) (0)
- P12.04: Can 4D STIC bi‐directional power Doppler tissue evaluation help discriminate between normal ovaries and ovarian cancer tumours? (2016) (0)
- Type C1 and C2 radical hysterectomy (2013) (0)
- 606 Prognostic significance of HPV DNA presence in lymph nodes in cervical cancer patients – a long term follow-up (2021) (0)
- P876 Prevalence of nonclassic adrenal hyperplasia (NCAH) in hyperandrogenic women (2009) (0)
- [Contraception in female diabetic patients]. (2002) (0)
- Methylation patterns in serum DNA for early identification of disseminated breast cancer (2017) (0)
- TP034/#1534 Randomized phase III trial on niraparib-TSR-042 (Dostarlimab) versus physician’s choice chemotherapy in recurrent ovarian, fallopian tube, primary peritoneal cancer platinum resistant patients: nitche trial(MITO 33) (2022) (0)
- Response to: Correspondence on "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors" by Thomassin-Nagarra et al (2021) (0)
- EP683 Management of pregnancy after fertility-sparing surgery for cervical cancer (2019) (0)
- OP24.09: Transrectal ultrasound in the evaluation of locally advanced cervical cancer after neoadjuvant chemotherapy (2009) (0)
- The efficacy of an algorithm using sentinel lymph node biopsy and frozen section in the avoidance of a combined treatment in early-stage cervical cancer management (2019) (0)
- 21TiP Molecular alterations predictive of outcome in early staged cervical cancer: A translational investigation in the international validation study of sentinel node biopsy in early cervical cancer SENTICOL III (2023) (0)
- [Detection of HPV DNA in lymph nodes in early stages cervical cancers]. (2008) (0)
- Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock (2022) (0)
- [[Endometrial ablation--prospective 5-year follow-up study]. (2000) (0)
- [Screening for factor V Leiden mutation in women using combined hormonal contraceptives or hormone replacement therapy]. (2003) (0)
- [Can hormonal contraception influence plasma levels of IGF-1 and IGEBP-1 in gracile women with polycystic ovary syndrome?] (2001) (0)
- OC229: Ultrasound‐guided tru‐cut biopsy in the management of advanced abdominopelvic tumors (2007) (0)
- Molecular testing in endometrial carcinoma (Joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists). (2021) (0)
- OC231: Transrectal ultrasound (TRUS) and MRI in staging of early cervical cancer (2007) (0)
- Abstract PR005: TP53 field defects in uterine fluid are associated with ovarian cancer risk (2022) (0)
- 2022-RA-222-ESGO Quality of life after extended pelvic exenterations (2022) (0)
- [Consensus statement regarding indications for Leiden (FVL-factor V Leiden) mutation determination when recommending combined hormonal contraception or hormone replacement therapy]. (2003) (0)
- 24th World Congress on Ultrasound in Obstetrics and Gynecology, 14–17 September 2014, Barcelona, Spain: presentations and awards (2014) (0)
- [Importance of operative hysteroscopy in the treatment of intrauterine pathology: method of first choice]. (1999) (0)
- Ovarian Cancer Screening There May Be Light at the End of the Tunnel? (2016) (0)
- The group with the most heterogenous treatment among patients with cervical cancer. (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David Cibula?
David Cibula is affiliated with the following schools:
